General Information of Drug (ID: DMI7DZ2)

Drug Name
Prilocaine Drug Info
Synonyms
Citanest; Prilocaina; Prilocainum; Propitocaine; Prilocaine [USAN]; Prilocaine base; Astra 1512; Astra 1515; L 67; Citanest (TN); Prilocaina [INN-Spanish]; Prilocainum [INN-Latin]; Propitocaine (JAN); Prilocaine (USP/INN); O-Methyl-2-propylaminopropionanilide; O-Methyl-alpha-propylaminopropionanilide; Alpha-n-Propylamino-2-methylpropionanilide; N-[2-Methylphenyl]-2-[propylamino]propanamide; N-(2-methylphenyl)-N2-propylalaninamide; N-(2-Methylphenyl)-2-(propylamino)propanamide; N-(2-methylphenyl)-N(2)-propylalaninamide; Propanamide, N-(2-methylphenyl)-2-(propylamino)-(9CI); 2-(Propylamino)-o-propionotoluidide; 2-Methyl-.alpha.-propylaminopropionanilide; 2-Methyl-alpha-propylaminopropionanilide
Indication
Disease Entry ICD 11 Status REF
Pain MG30-MG3Z Approved [1]
Premature ejaculation HA03.0Z Investigative [2]
Therapeutic Class
Anesthetics
Cross-matching ID
PubChem CID
4906
ChEBI ID
CHEMBL1194
CAS Number
CAS 721-50-6
TTD Drug ID
DMI7DZ2

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Mephenytoin DM5UGDK Epilepsy 8A60-8A68 Approved [4]
Mexiletine DMCTE9R Ventricular tachycardia BC71 Approved [5]
Fosphenytoin DMOX3LB Epilepsy 8A60-8A68 Approved [4]
Disopyramide DM5SYZP Long QT syndrome BC65.0 Approved [5]
LOMERIZINE DME0TC8 Migraine 8A80 Approved [6]
Tetrodotoxin DMWMPRG Bacterial infection 1A00-1C4Z Approved [7]
Dyclonine DMU6OFP Pain MG30-MG3Z Approved [3]
Moricizine DMOMBJW Arrhythmia BC9Z Approved [8]
Ethotoin DMXWOCP Complex partial seizure 8A68.0 Approved [9]
Hexylcaine DMEADRK Anaesthesia 9A78.6 Approved [9]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Voltage-gated sodium channel alpha Nav1.5 (SCN5A) TTZOVE0 SCN5A_HUMAN Blocker [3]

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7276).
2 Prilocaine FDA Label
3 Monoamine transporter and sodium channel mechanisms in the rapid pressor response to cocaine. Pharmacol Biochem Behav. 1998 Feb;59(2):305-12.
4 Lacosamide: a new approach to target voltage-gated sodium currents in epileptic disorders. CNS Drugs. 2009;23(7):555-68.
5 Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome. J Cardiovasc Electrophysiol. 2000 Dec;11(12):1320-9.
6 Medicinal chemistry of neuronal voltage-gated sodium channel blockers. J Med Chem. 2001 Jan 18;44(2):115-37.
7 Halothane attenuates the cerebroprotective action of several Na+ and Ca2+ channel blockers via reversal of their ion channel blockade. Eur J Pharmacol. 2002 Oct 4;452(2):175-81.
8 From first class to third class: recent upheaval in antiarrhythmic therapy--lessons from clinical trials. Am J Cardiol. 1996 Aug 29;78(4A):28-33.
9 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.